GLASSIA Infusion Rate Study

NCT01651351 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha1-antitrypsin Deficiency
Healthy Volunteers

Interventions

BIOLOGICAL: Alpha1-proteinase inhibitor
BIOLOGICAL: Placebo: Human albumin 2.5%

Sponsor

Baxalta now part of Shire